Export Ready — 

Studies on Renal Disorders /

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Miyata, Toshio. (Editor), Eckardt, Kai-Uwe. (Editor), Nangaku, Masaomi. (Editor)
Format: eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana, 2011.
Edition:1st ed. 2011.
Series:Oxidative Stress in Applied Basic Research and Clinical Practice,
Subjects:
Table of Contents:
  • Preface
  • Chapter 1. Oxidative stress injury in glomerular mesangium
  • Chapter 2. Transition Metals and other Forms of Oxidative Protein Damage in
  • Renal Disease
  • Chapter 3. Cyclo-oxygenase in the kidney and oxidative stress
  • Chapter 4. Renin angiotensin system in the kidney and oxidative stress -Local Renin-Angiotensin-Aldosterone-System and NAD(P)H oxidase-dependent oxidative stress in the kidney-
  • Chapter 5. Thiamine in diabetic renal disease - dietary insufficiency, renal
  • washout, anti-stress gene response, therapeutic supplements, risk predictor and link to genetic susceptibility
  • Chapter 6. Novel members of the globin family and their function against oxidative stress
  • Clinical Aspects of Oxidative Stress in the Kidney
  • Chapter 7. Hypertension
  • Chapter 8. Uric acid and oxidative stress
  • Chapter 9. Reactive oxygen and nitrogen species, oxidative and nitrosative
  • stress and their role in the pathogenesis of acute kidney injury
  • Chapter 10. Oxidative stress in the kidney: proximal tubule disorders
  • Chapter 11. Iron metabolism and oxidative stress
  • Chapter 12. Hypoxia, oxidative stress and the pathophysiology of contrast-media-induced nephropathy
  • Chapter 13. Cardiovascular complications in renal failure: implications of advanced glycation end-products and their receptor, RAGE
  • Chapter 14. Infection and the kidney
  • Chapter 15. Oxidative/carbonyl stress in the renal circulation and cardiovascular renal injury
  • Current Therapy Targeting Oxidative Stress
  • Chapter 16. Renin angiotensin system
  • Chapter 17. Oxidative stress in kidney injury-peroxisome proliferator-activated receptor- agonists are in control
  • Chapter 18. Statin
  • Chapter 19. N-acetylcysteine in kidney disease
  • Chapter 20. Advanced glycation end products (AGEs) inhibitor
  • Section 2. 'Hypoxia'
  • Hypoxia Biology
  • Chapter 21. Involvement of hypoxia-inducible factor 1 in physiological and pathological responses to continuous and intermittent hypoxia: Role of reactive oxygen species
  • Chapter 22. Regulation of oxygen homeostasis by PHDs
  • Chapter 23. Oxygen-dependent regulation of erythropoiesis
  • Chapter 24. Intricate link between hypoxia and oxidative stress in chronic kidney disease
  • Chapter 25. RNA interference and the regulation of renal gene expression in
  • hypoxia
  • Hypoxia Pathology in Renal Disorders
  • Chapter 26.Cardio-renal connection: The role of hypoxia and oxidative stress
  • Chapter 27. HIF in acute kidney injury - from pathophysiology to a novel approach of organ protection
  • Chapter 28. Hypoxia in chronic kidney disease: the final common pathway to end stage renal disease
  • Chapter 29. Oxidative stress and hypoxia in the pathogenesis of diabetic
  • nephropathy
  • Chapter 30. Estimation of kidney oxygenation by BOLD-MRI
  • Chapter 31. Anemia and progression of chronic kidney disease
  • Section 3. Novel therapeutic approaches against oxidative stress and hypoxia
  • Chapter 32. Novel therapeutic approaches against hypoxia and oxidative stress,targeting intracellular sensor molecules for oxygen and oxidative stress
  • Chapter 33. Endoplasmic reticulum (ER) stress as a target of therapy against oxidative stress and hypoxia
  • Chapter 34. Stem cell therapy against oxidative stress and hypoxia.